CALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ADECCO GROUP/SWISS LIFE HLDG Share Price

Certificat

RMAHAV

CH1308705966

Market Closed - Swiss Exchange 08:50:00 15/05/2024 pm IST
100.6 CHF +0.10% Intraday chart for CALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ADECCO GROUP/SWISS LIFE HLDG
Current month+4.36%
1 month+5.45%
Date Price Change
15/24/15 100.6 +0.10%
13/24/13 100.5 +1.01%
10/24/10 99.5 +2.05%

Delayed Quote Swiss Exchange

Last update May 15, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
RMAHAV
ISINCH1308705966
Date issued 15/12/2023
Strike 84.79 CHF
Maturity 16/06/2025 (395 Days)
Parity 0.08 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 100.6 CHF
Lowest since issue 92.5 CHF
Spread 8 CHF
Spread %0.79%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
107.9 USD
Spread / Average Target
+4.91%
Consensus
  1. Stock Market
  2. Certificates
  3. RMAHAV Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW